Pfizer start Lupus STUDY jointly 23andMe.

Have problems with lupus, an autoimmune disease in which the disease fighting capability can attack the normal, healthy tissues of the body almost anywhere. Some of the more prevalent medical indications include joint inflammation, skin sores and rashes, as well as kidney, heart, and lung damage. While the cause of lupus is unknown, study indicates that it’s linked to a true number of factors, including genetics, hormones and environmental elements. There is no known treatment for the disease. The capability to effectively personalize remedies for lupus patients is limited, due in large component to our incomplete understanding of the disease, stated 23andMe CEO and co-founder Anne Wojcicki. We hope to transformation that by learning human genetics alongside environmental and health history factors to ultimately help inform better treatment plans for lupus patients.While traditional monofocal IOLs are made to restore much or distance vision, multifocal IOLs offer quality eyesight at multiple distances and reduce or eliminate the need for eyeglasses. The new lenses approved by the U.S. Drug and Food Administration are referred to as TECNIS Multifocal +2.75D and +3.25D IOLs. Together with the obtainable TECNIS Multifocal +4.0D IOL, all the TECNIS Multifocal IOLs provide excellent vision at near, intermediate and far distances, while each lens power version provides improved vision at a distinct distance.